Sepsis is an important cause of mortality and morbidity in neonatal populations. There has
been constant search of an ideal sepsis biomarker that have high sensitivity, specificity …

Neonatal sepsis is associated with severe morbidity and mortality in the neonatal period.
Clinical manifestations range from subclinical infection to severe local or systemic infection …

Neonatal sepsis, a clinical disorder developed by bacterial blood stream infections (BSI) in
neonates, is one of the serious global public health problems that must be addressed. More …

Several biochemical markers have been proposed over the past years to manage critically ill
newborns with acute inflammation and sepsis. The state of the art in diagnosing and …

Sepsis currently remains a major contributor to mortality in the intensive care unit (ICU), with
48.9 million cases reported globally and a mortality rate of 22.5% in 2017, accounting for …

Septic shock is a critical clinical condition with a high mortality rate. A better understanding
of the underlying mechanisms is important to develop effective therapies. Basic and clinical …

Inter-α inhibitor proteins (IAIPs) are a family of endogenous plasma and extracellular matrix
molecules. IAIPs suppress proinflammatory cytokines, limit excess complement activation …

As a leading cause of neonatal morbidity and mortality, neonatal sepsis remains a
significant global health challenge. Despite recent advances in the management of neonatal …

Sepsis usually leads to lethal multiorgan dysfunction including acute liver failure (ALF) and
acute lung injury (ALI). This research sought to reveal the lipid alteration of anti-high mobility …

Systemic inflammation resulting from the release of pro-inflammatory cytokines and the
chronic activation of the innate immune system remains a major cause of morbidity and …